For specialists, one of the most difficult aspects of treating mesothelioma is deciding which treatment will be the most effective for the patient. A patient’s diagnosis can vary greatly by stage, cell type, and location of the tumor, all of which affect their prognosis. Now that immunotherapy...
Read More
Advances in imaging technology for early detection of mesothelioma as well as immunotherapy used in multimodal treatments have recently shown great promise to extend life...
Read Post
Over 20 years ago, researchers at the National Cancer Institute (NCI) discovered the antigen, mesothelin. To this day, it has been an attractive target for investigative studies...
Read Post
When a patient is diagnosed with mesothelioma, the goal of any sort of treatment regimen is to give them the best possible chance at extending their life. Historically, since...
Read Post
With pleural mesothelioma cases on the rise, it is more important than ever for new methods of detection and treatment to be researched. One of the most promising in terms of...
Read Post
National Cancer Institute Joins U.S. Department of Veterans Affairs Clinical trials provide hope and new treatment opportunities to all mesothelioma warriors, including veterans....
Read Post
DREAM Clinical Trial Produces Encouraging Results A clinical trial hosted in Australia may have victorious results in treating pleural mesothelioma. However, researchers agree...
Read Post
Grant Renewed at CARD Clinic A $2.5 million grant has been awarded to the Center for Asbestos Related Disease (CARD). This clinic in Libby, Montana specializes in asbestos-related...
Read Post
President Donald Trump Signs VA MISSION Act Across the country, veterans combating mesothelioma and their caregivers are thankful for the VA MISSION Act of 2018. The bill was...
Read Post
New Law Provides Hope to Terminally Ill Patients President Trump gave his seal of approval by signing the Right to Try Act. This new law provides hope to mesothelioma warriors and...
Read Post